Head-to-head · WeighScore
Intimate Rose vs Vaylen
By GLP-1 ScorecardUpdated
Score comparison
Vaylen has the higher recorded score — 77.9/100 to 65.1/100.
Vaylen grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Vaylen is a pure GLP-1 specialist offering compounded semaglutide ($179/mo), compounded tirzepatide ($239/mo), compounded oral GLP-1 ($259/mo), and brand-name Ozempic, Zepbound, and Wegovy.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Intimate Rose | Vaylen |
|---|---|---|
| WeighScore | 65.1/100 | 77.9/100 |
| Grade | C | C+ |
| Site position | #253 | #46 |
| Semaglutide | $169/mo (all doses, compounded) | $179/mo (compounded) |
| Tirzepatide | $169/mo (all doses, compounded) | $239/mo (compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #253 · C
FDAWarning letter issued to Intimate Rose in September 2025. See the FDA warning-letter database.
Strengths
- Transparent pricing from 169 dollars per month shown upfront, not gated behind intake
- Medication and free delivery included, HSA and FSA eligible, no contract
- Backed by an established women's-health brand using the OpenLoop provider network
What to consider
- State availability not published
- Oral compounded GLP-1 only; no injectable option shown
- No specific compounding pharmacy named (network fulfillment via OpenLoop)
- FDA issued Intimate Rose a warning letter in September 2025; the letter is public in FDA's warning-letter database
Site position #46 · C+
Strengths
- Pure GLP-1 specialist — not a multi-category telehealth platform
- All 50 states coverage with licensed clinicians
- Both compounded and brand-name options (Ozempic, Wegovy, Zepbound)
- Oral GLP-1 option (compounded dissolvable tablets) for needle-averse patients
- LegitScript certified
What to consider
- Compounded semaglutide at $179/mo is mid-range (not the cheapest)
- Brand-name options at near-retail pricing ($997-$1,086/mo)
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.